Thayer E

ORCID: 0000-0002-8800-5273 · 1 paper in corpus

2023

Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?

Gynecologic oncology reports ·doi:10.1016/j.gore.2023.101140

ObjectiveThe COVID-19 vaccine is known to instigate an inflammatory response that impacts cancer testing. We aimed to evaluate carbohydrate antigen 125 (CA-125) trends in gynecologic oncology patients in surveillance following COVID-19 vacc…